Use of Johnson & Johnson's COVID-19 vaccine should be resumed in the United States despite evidence that it is linked to extremely rare but potentially deadly blood clots, advisers to the U.S. Centers for Disease Control and Prevention (CDC) recommended on Friday.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.